Genetic Metabolic Diseases AC's First Meeting Will Be Long On Temporary Voting Members
Executive Summary
The US FDA’s Genetic Metabolic Diseases Advisory Committee will comprise three regular voting members and 13 temporary members, including some adcomm veterans, when it reviews Zevra Denmark’s arimoclomol for Niemann-Pick disease type C.